Report #2843117

Overview

Sex

Female

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

Oct 1, 2021

Onset

—

Days to onset

—

Hospital days

—

Symptoms (2)

Symptom narrative

I stopped getting the vaccine because I was diagnosed with ITP; This serious case was reported by a consumer via call center representative and described the occurrence of idiopathic thrombocytopenic purpura in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. In OCT-2021, the patient received the 1st dose of Shingrix (left arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced idiopathic thrombocytopenic purpura (Verbatim: I stopped getting the vaccine because I was diagnosed with ITP) (serious criteria GSK medically significant). The outcome of the idiopathic thrombocytopenic purpura was not reported. It was unknown if the reporter considered the idiopathic thrombocytopenic purpura to be related to Shingrix. The company considered the idiopathic thrombocytopenic purpura to be unrelated to Shingrix. Additional Information: GSK Receipt Date: 05-MAY-2025 The reporter was the patient. The patient received the 1st dose of Shingrix at a local pharmacy in October 2021. The vaccine was administered in the left arm. The patient reported due to medical reasons she was unable to get the 2nd dose 2 to 6 months after; and received the 2nd dose at her doctor's office in April 2025 in the left arm. The patient reported that recently in the past 3 years he stopped getting the vaccine because he was diagnosed with ITP The customer denied demographics, and the agent was unable to obtain any additional information.; Sender's Comments: Immune thrombocytopenia is an unlisted event which is considered unrelated to GSK vaccine Shingrix.